Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Conso
about
Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant ConsortiumEfficacy of lentiviral mediated gene therapy in an Omenn syndrome Rag2 mouse model is not hindered by inflammation and immune dysregulation.Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment.
P2860
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Conso
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Current Knowledge and Prioriti ...... od and Marrow Transplant Conso
@en
type
label
Current Knowledge and Prioriti ...... od and Marrow Transplant Conso
@en
prefLabel
Current Knowledge and Prioriti ...... od and Marrow Transplant Conso
@en
P2093
P2860
P1476
Current Knowledge and Prioriti ...... od and Marrow Transplant Conso
@en
P2093
Andrew C Dietz
Andrew R Gennery
Benedicte Neven
Christine Duncan
Elie Haddad
Jennifer Heimall
Jennifer Puck
K Scott Baker
Luigi D Notarangelo
Mary Slatter
P2860
P304
P356
10.1016/J.BBMT.2016.12.619
P577
2017-01-06T00:00:00Z